215 related articles for article (PubMed ID: 33911106)
1. A survey of the kinome pharmacopeia reveals multiple scaffolds and targets for the development of novel anthelmintics.
Knox J; Joly N; Linossi EM; Carmona-Negrón JA; Jura N; Pintard L; Zuercher W; Roy PJ
Sci Rep; 2021 Apr; 11(1):9161. PubMed ID: 33911106
[TBL] [Abstract][Full Text] [Related]
2. Anthelmintic drug actions in resistant and susceptible C. elegans revealed by electrophysiological recordings in a multichannel microfluidic device.
Weeks JC; Robinson KJ; Lockery SR; Roberts WM
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):607-628. PubMed ID: 30503202
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the molecular determinants of cholinergic anthelmintic sensitivity in nematodes: When novel functional validation approaches highlight major differences between the model Caenorhabditis elegans and parasitic species.
Blanchard A; Guégnard F; Charvet CL; Crisford A; Courtot E; Sauvé C; Harmache A; Duguet T; O'Connor V; Castagnone-Sereno P; Reaves B; Wolstenholme AJ; Beech RN; Holden-Dye L; Neveu C
PLoS Pathog; 2018 May; 14(5):e1006996. PubMed ID: 29719008
[TBL] [Abstract][Full Text] [Related]
4. Caenorhabditis elegans is a useful model for anthelmintic discovery.
Burns AR; Luciani GM; Musso G; Bagg R; Yeo M; Zhang Y; Rajendran L; Glavin J; Hunter R; Redman E; Stasiuk S; Schertzberg M; Angus McQuibban G; Caffrey CR; Cutler SR; Tyers M; Giaever G; Nislow C; Fraser AG; MacRae CA; Gilleard J; Roy PJ
Nat Commun; 2015 Jun; 6():7485. PubMed ID: 26108372
[TBL] [Abstract][Full Text] [Related]
5. Using existing drugs as leads for broad spectrum anthelmintics targeting protein kinases.
Taylor CM; Martin J; Rao RU; Powell K; Abubucker S; Mitreva M
PLoS Pathog; 2013 Feb; 9(2):e1003149. PubMed ID: 23459584
[TBL] [Abstract][Full Text] [Related]
6. Discovery of ML358, a Selective Small Molecule Inhibitor of the SKN-1 Pathway Involved in Drug Detoxification and Resistance in Nematodes.
Peddibhotla S; Fontaine P; Leung CK; Maloney P; Hershberger PM; Wang Y; Bousquet MS; Luesch H; Mangravita-Novo A; Pinkerton AB; Smith LH; Malany S; Choe K
ACS Chem Biol; 2015 Aug; 10(8):1871-9. PubMed ID: 25946346
[TBL] [Abstract][Full Text] [Related]
7. Phylum-Spanning Neuropeptide GPCR Identification and Prioritization: Shaping Drug Target Discovery Pipelines for Nematode Parasite Control.
Atkinson LE; McCoy CJ; Crooks BA; McKay FM; McVeigh P; McKenzie D; Irvine A; Harrington J; Rosa BA; Mitreva M; Marks NJ; Maule AG; Mousley A
Front Endocrinol (Lausanne); 2021; 12():718363. PubMed ID: 34659113
[TBL] [Abstract][Full Text] [Related]
8. Chemogenomic approach to identifying nematode chemoreceptor drug targets in the entomopathogenic nematode Heterorhabditis bacteriophora.
Motaher R; Grill E; McKean E; Kenney E; Eleftherianos I; Hawdon JM; O'Halloran DM
Comput Biol Chem; 2021 Jun; 92():107464. PubMed ID: 33667976
[TBL] [Abstract][Full Text] [Related]
9. Diisopropylphenyl-imidazole (DII): A new compound that exerts anthelmintic activity through novel molecular mechanisms.
Blanco MG; Vela Gurovic MS; Silbestri GF; Garelli A; Giunti S; Rayes D; De Rosa MJ
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007021. PubMed ID: 30557347
[TBL] [Abstract][Full Text] [Related]
10. A highly conserved, inhibitable astacin metalloprotease from Teladorsagia circumcincta is required for cuticle formation and nematode development.
Stepek G; McCormack G; Winter AD; Page AP
Int J Parasitol; 2015 Apr; 45(5):345-55. PubMed ID: 25736599
[TBL] [Abstract][Full Text] [Related]
11. Activity of novel nicotinic anthelmintics in cut preparations of Caenorhabditis elegans.
Ruiz-Lancheros E; Viau C; Walter TN; Francis A; Geary TG
Int J Parasitol; 2011 Mar; 41(3-4):455-61. PubMed ID: 21195075
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput screen for the identification of compounds that inhibit nematode gene expression by targeting spliced leader trans-splicing.
Pandarakalam GC; Speake M; McElroy S; Alturkistani A; Philippe L; Pettitt J; Müller B; Connolly B
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():28-37. PubMed ID: 31015150
[TBL] [Abstract][Full Text] [Related]
13. Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans.
Holden-Dye L; Walker RJ
WormBook; 2014 Dec; ():1-29. PubMed ID: 25517625
[TBL] [Abstract][Full Text] [Related]
14. Identification of compounds with bioactivity against the nematode Caenorhabditis elegans by a screen based on the functional genomics of the marine bacterium Pseudoalteromonas tunicata D2.
Ballestriero F; Thomas T; Burke C; Egan S; Kjelleberg S
Appl Environ Microbiol; 2010 Sep; 76(17):5710-7. PubMed ID: 20601498
[TBL] [Abstract][Full Text] [Related]
15. A new class of anthelmintics effective against drug-resistant nematodes.
Kaminsky R; Ducray P; Jung M; Clover R; Rufener L; Bouvier J; Weber SS; Wenger A; Wieland-Berghausen S; Goebel T; Gauvry N; Pautrat F; Skripsky T; Froelich O; Komoin-Oka C; Westlund B; Sluder A; Mäser P
Nature; 2008 Mar; 452(7184):176-80. PubMed ID: 18337814
[TBL] [Abstract][Full Text] [Related]
16. Caenorhabditis elegans muscle Cys-loop receptors as novel targets of terpenoids with potential anthelmintic activity.
Hernando G; Turani O; Bouzat C
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007895. PubMed ID: 31765374
[TBL] [Abstract][Full Text] [Related]
17. Heterologous Expression in Remodeled C. elegans: A Platform for Monoaminergic Agonist Identification and Anthelmintic Screening.
Law W; Wuescher LM; Ortega A; Hapiak VM; Komuniecki PR; Komuniecki R
PLoS Pathog; 2015 Apr; 11(4):e1004794. PubMed ID: 25928899
[TBL] [Abstract][Full Text] [Related]
18. Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans.
van der Hoeven D; Truong TNL; Naji A; Thapa S; Hancock JF; van der Hoeven R
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33074252
[TBL] [Abstract][Full Text] [Related]
19. An automated high-throughput system for phenotypic screening of chemical libraries on C. elegans and parasitic nematodes.
Partridge FA; Brown AE; Buckingham SD; Willis NJ; Wynne GM; Forman R; Else KJ; Morrison AA; Matthews JB; Russell AJ; Lomas DA; Sattelle DB
Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):8-21. PubMed ID: 29223747
[TBL] [Abstract][Full Text] [Related]
20. Atypical (RIO) protein kinases from Haemonchus contortus--promise as new targets for nematocidal drugs.
Campbell BE; Boag PR; Hofmann A; Cantacessi C; Wang CK; Taylor P; Hu M; Sindhu ZU; Loukas A; Sternberg PW; Gasser RB
Biotechnol Adv; 2011; 29(3):338-50. PubMed ID: 21262337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
